Oncology

Latest News

AJMC Q&A with Robert Kratzke | Background image credit: ipopba - stock.adobe.com
Ensuring Coverage of Faster Biomarker Testing in Lung Cancer: Robert Kratzke, MD

July 15th 2025

Robert Kratzke, MD, urged insurance providers to prioritize fast biomarker testing in non–small cell lung cancer, saying it’s both cost-effective and life-saving.

The investigators found that patients with SCLC and cachexia were more likely to have problems with treatment. | Image credit: appledesign - stock.adobe.com
Cachexia Worsens Prognosis in Older Patients With Advanced SCLC

July 9th 2025

Insurance gaps | Image Credit: iQoncept-stock.adobe.com
Insurance Gaps Threaten Cancer Treatment Success

July 7th 2025

Analyzed by birth cohort, the authors found each successive birth cohort had a 7.7% decline in SCLC rates. | Image credit: shidlovski
Decline in SCLC Incidence Expected to Accelerate Through 2050

June 29th 2025

While elevated NLR previously served as a marker of aggressive disease and poor prognosis in SCLC, its prognostic relevance appears to diminish in the context of immunotherapy-based treatment regimens. | Image credit: Crystal light - stock.adobe.com
Challenging the Prognostic Role of NLR in SCLC in the Era of Immunotherapy

June 27th 2025

Join this expert panel to discuss precision medicine in NSCLC, current immunotherapies, and more.

Watch the series now!

Join a panel of leaders as they discuss treatment for patients diagnosed with metastatic NSCLC without driver mutations
Continuing Medical Education
View All
July 15th 2025

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

1 Credit / Cardiology, Neurology
July 15th 2025

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health

More News

Site Logo
April 18th 2017

Value-Based Payment Models in Oncology: Will They Help or Hinder Patient Access to New Treatments?

Sonal Shah, PharmD Greg Reh
The Deloitte Center for Health Solutions recently interviewed individuals from health plans, providers, and clinical pathway developers that are participating, supporting, or evaluating oncology payment models to understand what approaches are perceived to be working, the early results, and the potential impact on innovation.
Site Logo
April 18th 2017

Atezolizumab Now a First-Line Option for Cisplatin-Ineligible Patients With Advanced Bladder Cancer

Surabhi Dangi-Garimella, PhD
The approval comes following phase 2 results of 119 patients who participated in the IMvigor210 study.
Dr Marianne Fazen on the Value for Employers in the Oncology Care Model
April 18th 2017

Dr Marianne Fazen on the Value for Employers in the Oncology Care Model

Oncology care management helps coordinate the clinical aspects of cancer treatment, but it would also be helpful to have a benefits manager to help guide patients through their many options, said Marianne Fazen, PhD, president and CEO of the Texas Business Group on Health.
Site Logo
April 17th 2017

An Oncologist's Perspective: Preparation for New Payment Models in Cancer Care

Sachin M. Apte, MD, MS, MBA
A dive into the Quality Payment Program and other healthcare reform models introduced in cancer care that healthcare providers are adjusting to as we move toward value-based care.
Site Logo
April 17th 2017

How to Create Successful Alternative Payment Models in Oncology

Harold D. Miller
By identifying ways to improve cancer care and then designing alternative payment models (APMs) to overcome current payment barriers, APMs can enable oncology practices to deliver better care to patients and save money for payers in a way that is financially sustainable for the practices.
Site Logo
April 17th 2017

Four in Five Mentally Ill Women on California Medicaid Not Screened for Cervical Cancer

Christina Mattina
A new study has found some concerning gaps in cervical cancer screening among a vulnerable population: women with severe mental illness enrolled in a state Medicaid program.
Site Logo
April 17th 2017

Study Questions Validity of Genetic Variant Classification in Public Databases

Surabhi Dangi-Garimella, PhD
A study published in The Oncologist concluded that discrepant variant classification in public databases can introduce uncertainty and diminish patient care.
Podcast: This Week in Managed Care - Guidelines Controversy, and Other News
April 15th 2017

Podcast: This Week in Managed Care - Guidelines Controversy, and Other News

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.
This Week in Managed Care: April 14, 2017
April 14th 2017

This Week in Managed Care: April 14, 2017

This week, the top managed care stories include an update for prostate cancer screening guidelines; the consequences of conflicting breast cancer guidelines; and Florida seeks work requirements for Medicaid.
Site Logo
April 13th 2017

Are Surgeons Adept at Handling BRCA1/2 Mutations of Uncertain Significance?

Surabhi Dangi-Garimella, PhD
Study identifies need for surgeons to maximize benefits of genetic testing for surgical decisions in breast cancer.
Site Logo
April 12th 2017

Oral Chemotherapy Adherence Affected by Patient Satisfaction With Oncologist and Treatment

Christina Mattina
A new study has explored factors that impact patient adherence to oral chemotherapy regimens and found that improved satisfaction with their treatment and clinician was most strongly linked to better adherence.
Site Logo
April 11th 2017

Alternative to Colonoscopy Is Now in Medicare's Star Ratings

Mary Caffrey
Adding a test that evaluates stool samples for DNA and protein biomarkers to the list of tools providers can use to boost quality ratings is seen as an additional boost for Cologuard.
Site Logo
April 11th 2017

Conflicting Breast Cancer Screening Guidelines Lead to Varying Physician Recommendations

Christina Mattina
A new study published in JAMA Internal Medicine has found that the extent to which clinicians follow breast cancer screening guidelines for patients of different ages varies by their specialty and by which set of recommendations they trust most.
Site Logo
April 11th 2017

Fetal Exposure to Cigarette Smoke Causes Genetic Changes, Raises Risk of Pediatric ALL

Surabhi Dangi-Garimella, PhD
Exposure to tobacco smoke as a fetus or during early childhood can cause genetic changes that can increase a child’s risk of developing acute lymphoblastic leukemia (ALL).
Site Logo
April 11th 2017

What We're Reading: SCOTUS to Hear Biosimilar Case; Prostate Cancer Screening; Fitness Trackers

AJMC Staff
Dr David L. Porter Discusses Side Effects of CAR-T Cell Therapy
April 11th 2017

Dr David L. Porter Discusses Side Effects of CAR-T Cell Therapy

CAR-T cell treatment can have a number of side effects, with the most serious being cytokine release syndrome, according to David L. Porter, MD, of the University of Pennsylvania Health System. However, there are some promising therapies like interleukin-6 blockers that can reverse this reaction.
Site Logo
April 10th 2017

Hospice Use Less Common for Minority Women With Ovarian Cancer

Christina Mattina
A new study finds that women with ovarian cancer who were black or Hispanic tended to undergo more aggressive treatment and were less likely to receive hospice services at the end of life.
Site Logo
April 10th 2017

Do We Need Biomarkers to Predict Tumor Hyper-Progression Following Immunotherapy?

Surabhi Dangi-Garimella, PhD
A new study published in Clinical Cancer Research provides evidence that researchers can use biomarkers to identify patients whose tumors will grow at a faster rate following immunotherapy treatment.
Samantha Watson on the Importance of Patient-Provider Discussions About Cancer Costs
April 9th 2017

Samantha Watson on the Importance of Patient-Provider Discussions About Cancer Costs

Providers have a responsibility to discuss the costs of cancer care with their patients earlier on, so the patients aren’t blindsided by enormous bills, said Samantha Watson, founder and CEO of The Samfund. These conversations would help patients prepare for the financial realities associated with cancer.
Site Logo
April 9th 2017

Racial Disparities in Health-Related Quality of Life for Patients With Colorectal Cancer

AJMC Staff
Hispanics and blacks with colorectal cancer report a higher burden of poor health-related quality of life (HR-QoL) compared with white patients, according to study results presented at the annual meeting of the American Association for Cancer Research.
Site Logo
April 7th 2017

FDA to Permit Marketing of Direct-to-Consumer Tests for Genetic Health Risks

Christina Mattina
In a reversal of previous policy, the FDA has announced it will allow the genetic testing company 23andMe to market its DNA tests directly to consumers.
Site Logo
April 7th 2017

Clinical Pathways Successfully Drive Physicians to Lower-Cost Regimens in Colorectal Cancer

Laura Joszt, MA
Clinical pathways can successfully be used to drive physicians to choose a less costly regimen when the efficacy and toxicity of different treatment regimens for metastatic colorectal cancer are comparable, according to a study in the Journal of Oncology Practice.
Site Logo
April 6th 2017

AACR Study Finds Shift in Cancer Burden in HIV-Positive Individuals

Surabhi Dangi-Garimella, PhD
A study presented at the annual meeting of the American Association for Cancer Research predicts a shift in the number and the pattern of cancer incidence among those infected with the human immunodeficiency virus (HIV).
Site Logo
April 5th 2017

Surge in Thyroid Cancer Cases and Deaths Not the Result of Overdiagnosis, Study Says

Christina Mattina
Over the last 4 decades, the incidence of thyroid cancer has risen by an average 3.6% per year, according to a recent analysis of cancer registry data. Researchers believe this reflects a true increase in the cancer’s occurrence that cannot be explained by overdiagnosis.
Site Logo
April 5th 2017

ASCO Supports FDA's Expanded Access Program, Wary of Right to Try

Surabhi Dangi-Garimella, PhD
The American Society of Clinical Oncology (ASCO) has released a statement raising serious concerns about right to try, while strongly supporting the FDA’s expanded access program.
Site Logo
April 4th 2017

ACA Poll Shows Cancer Patient Attitudes Toward Healthcare Law

PatientsLikeMe
A poll conducted by PatientsLikeMe shows that cancer patients have the same concerns as the general population about healthcare costs, but see benefits in the law that the healthy may have overlooked.
Dr Karen van Caulil Says Patients Are Top Priority for Employers
April 4th 2017

Dr Karen van Caulil Says Patients Are Top Priority for Employers

It can be difficult at times for the Florida Health Care Coalition to meet the needs of every stakeholder, but the patient’s best interest is always at the center, said Karen van Caulil, PhD, president and CEO of the Florida Health Care Coalition. The organization works with task forces and advisory groups to find solutions that put the patient first.
Site Logo
April 3rd 2017

Standardized Cancer Palliative Care Consults Linked to Stronger Home-Based Support

Christina Mattina
According to new research, a program that used standardized criteria to trigger palliative care consultations for patients with advanced cancer was associated with lower use of chemotherapy, fewer readmissions, and increased utilization of home-based support services after discharge.
Site Logo
April 3rd 2017

Encouraging 5-Year Survival Data With Nivolumab in Advanced NSCLC

Surabhi Dangi-Garimella, PhD
The 5-year survival estimate from a study evaluating nivolumab in a subset of patients with advanced non-small cell lung cancer (NSCLC) is significantly longer following treatment discontinuation.
Podcast: This Week in Managed Care - New Breast Cancer Guidelines, and Other News
April 1st 2017

Podcast: This Week in Managed Care - New Breast Cancer Guidelines, and Other News

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.
<1
...
787980818283848586
...
186>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo